Serological diagnosis of Chlamydophila pneumoniae infection in Greek COPD patients by microimmunofluorescence and ELISA

Medical Science Monitor

Volumn 14, Issue 9, 2008, Pages

  Papaetis, Georgios S ^a,c   Anastasakou, Evgenia ^b   Tselou, Theofania ^b   Karapanagiotou, Eleni ^a   Botsis, Taxiarchis ^a   Roussou, Paraskeui ^a   Orphanidou, Dora ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Chlamydia pneumoniae; COPD; Exacerbation; MIF

Indexed keywords

ADULT; AGED; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GREECE; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTI-BACTERIAL AGENTS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GREECE; HUMANS; LENGTH OF STAY; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 52249110452     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Fujita M, Nakanishi Y: The pathogenesis of COPD: lessons learned from in vivo animal models. Med Sci Monit, 2007; 13(2): RA19-24
2. Siafakas NM, Vermeire P, Pride NE et al: Optimal assessment, and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J, 1995; 8: 1398-50
3. Kanazawa H: Role of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Med Sci Monit, 2007; 13(11): RA189-95
4. Sethi S: Bacterial infection and the pathogenesis of COPD. Chest, 2000; 117: 286-91
5. Marrie TJ. Chlamydia pneumoniae. Thorax, 1993; 48: 1-4
6. Kauppinen MT, Saikku P: Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis and treatment. Clin Infect Dis, 1995; 21: 244-55
7. Beaty CD, Grayston JT, Wang S-P et al: Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis, 1991; 144: 1408-10
8. Blasi F, Legnani D, Lombardo VM et al: Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J, 1993; 6: 19-22
9. Miyashita N, Niki Y, Nakajima M et al: Chlamydia pneumoniae infection in patients with diffuse panbronciolitis and COPD. Chest, 1998; 114: 969-71
10. Lieberman D, Ben-Yaakov M, Lazarovich Z et al: Chlamydia pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease: analysis of 250 hospitalizations. Eur J Clin Microbiol Infect Dis, 2001; 20: 698-704
11. Karnak D, Beng-sun S, Beder S, Kayacan O: Chlamydia pneumoniae in fection and acute exacerbation of chronic obstructive pulmonary disease (COPD). Respir Med, 2001; 95: 811-16
12. Heinemann M, Susa M, Simnacher U et al: Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in human monocytic cell line. Infect Immun, 1996; 64: 4872-75
13. Von Hertzen L, Alakärppä H, Koskinen R et al: Chlamydia pneumoniae in fection in patients with chronic obstructive pulmonary disease. Epidemiol Infect, 1997; 118: 155-64
14. Blasi F, Damato S, Cosentini R et al: Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. Thorax, 2002; 57: 672-76
15. Kurashima K, Kanauchi T, Takayanagi N et al: Serum IgG and IgA antibodies to Chlamydia pneumoniae and severity of emphysema. Respirology, 2005; 10: 572-78
16. American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1995; 152(Suppl): 77-121
17. National Institutes of Health, National Heart, Lung and Blood Institute. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Report. Update 2003, www.goldcopd.com
18. Quanjer PH, Tammelimg GJ, Cotes JE et al: Lung volumes and forced ventilatory flows. Report of the Working Party for the Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society, European Respiratory Journal, 1993; 16 (Suppl.): 5-40
19. Jauhiainen T, Tuomi T, Leinonen M et al: Interference of immunoglobulin G (IgG) antibodies in IgA antibody determination for Chlamydia pneumoniae by micro-immunofluorescence test. J Clin Microbiol, 1994; 32: 839-40
20. Verkooyen RP, Hazenberg MA, Van Haaren GH et al: Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor. J Clin Microbiol, 1992; 30: 1287-90
21. Peeling RW, Wang SP, Grayston JT et al: Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. J Infect Dis, 2000; 181(Suppl.3): S426-29
22. Wang SP, Grayston JT: Immunological relationship between genital TRIC, lymphogranuloma venerum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol, 1970; 70: 367-74
23. Verkooyen RP, Van Lent NA, Mousavi Joulandan SA et al: Diagnosis of Chlamydia pneumoniae infection in chronic obstructive pulmonary disease patients by using microimmunofluorescence and ELISA. J Med Microbiol, 1997; 46: 959-64
24. Kern DG, Neill MA, Schachter J: A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity. Chest, 1993; 104: 208-13
25. Steinhoff D, Lode H, Ruckdeschel G et al: Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin. Clin Infect Dis, 1996; 22: 958-64
26. Verkooyen RP, Willemse D, Hiep-van Casteren SC et al: Evaluation of PCR, culture and serology for diagnosis of Chlamydia pneumoniae respiratory infections J Clin Microbiol, 1998; 36: 2301-7
27. Hyman CL, Augenbraun MH, Roblin PM et al: Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR. J Clin Microbiol, 1991; 29: 2082-53
28. Hyman CL, Roblin PM, Gaydos CA et al: Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis, 1995; 20: 1174-78
29. Gaydos CA, Roblin PM, Hammerschlag MR et al: Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients patients. J Clin Microbiol, 1994; 32: 903-5
30. Schmidt SM, Muller CE, Krechting M et al: Chlamydia pneumoniae carriage and infection in hospitalized children with respiratory tract diseases. Infection, 2003; 31: 410-16
31. Ekman MR, Leinonen M, Syrjala H et al: Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Filand. Eur J Clin Microbiol Infect Dis, 1993; 12: 756-60
32. Miyashita N, Obase Y, Minoru F et al: Evaluation of serological tests detecting Chlamydophila pneumoniae-specific immunoglobulin M antibody. Intern Med, 2006; 45: 1127-31
33. Mills GD, Oehley MR, Arrol B: Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ, 2005; 330(7489): 456
34. Bennedsen ML, Berthelsen L, Lind I: Performance of three microimmunofluorescence assays for detection of Chlamydia pneumoniae immunoglobulin M, G, and A antibodies. Clin Diagn Lab Immunol, 2002; 9: 833-39
35. Hermann C, Gueinzius K, Oehme A et al: Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections. J Clin Microbiol, 2004; 42: 2476-79
36. Hermann C, Graf K, Groh A et al: Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals. J Clin Microbiol, 2002; 40: 1603-9
37. Gutierrez J, Mendoza J, Fernandez F et al: ELISA test to detect Chlamydophila pneumoniae IgG. J Basic Microbiol, 2002; 42: 13-18
38. Von Hertzen LC: Chlamydia pneumoniae and its role in chronic obstructive pulmonary disease. Ann Med, 1998; 30: 27-37
39. Miyashita N, Niki Y, Nakajima M et al: Prevalence of asymptomatic infection with Chlamydia pneumoniae subjectively healthy adults. Chest, 2001; 119: 1416-19
40. Wu L, Skinner SJM, Lambie N et al: Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2000; 162: 1148-51
41. Mendall MA, Carrington D, Strachan D et al: Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect, 1995; 30; 121-28
42. Dahlen GH, Boman J, Birgander LS, Lindblom B: Lp(a) lipoprotein, IgG, IgA, IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis, 1995; 114: 165-74
43. Vestbo J, Prescott E, Lange P: Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med, 1996; 153: 1530-35
44. Lange P, Nyboe J, Appleyard M et al: Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax, 1990; 45: 579-85
45. Soler N, Ewig S, Torres A et al: Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J, 1999; 14: 1015-22
46. Sethi S, Maloney J, Grove L et al: Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2006; 173: 991-98
47. Incorvaia C, Riario-Sforza GG, Pravettoni C et al: Incidence and characteristics of hospital-acquired pneumonia in a pulmonary rehabilitation setting. Med Sci Monit, 2008; 14(4): CR196-98
48. Gieffers J, van Zandbergen G, Rupp J et al: Phagocytes transmit Chlamydia pneumoniae from the lung to the vasculature. Eur Respir J, 2004; 23: 506-10
49. Gieffers J, Fullgraft H, Jahn J et al: Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation, 2001; 103: 351-56
50. Stephens PS: The cellular paradigm of chlamydia pathogenesis. TRENDS Microbiol, 2003; 11: 44-51
51. Aller MA, Arias JL, Sanchez-Patan F, Arias J: The inflammatory response: an efficient way of life. Med Sci Monit, 2006; 12(10): RA225-34